These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24506579)

  • 1. Cefepime-induced encephalopathy in patients with haematological malignancies: clinical features and risk factors.
    Ugai T; Morisaki K; Tsuda K; Sugihara H; Nishida Y; Yamakura M; Takeuchi M; Matsue K
    Scand J Infect Dis; 2014 Apr; 46(4):272-9. PubMed ID: 24506579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal failure is a risk factor for cefepime-induced encephalopathy.
    Garces EO; Andrade de Anzambuja MF; da Silva D; Bragatti JA; Jacoby T; Saldanha Thomé F
    J Nephrol; 2008; 21(4):526-34. PubMed ID: 18651542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neurotoxicity and safety of treatment with cefepime in patients with renal failure.
    Sonck J; Laureys G; Verbeelen D
    Nephrol Dial Transplant; 2008 Mar; 23(3):966-70. PubMed ID: 18175786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefepime-Induced Encephalopathy in a Tertiary Medical Center in Korea.
    Jeon JY; Cho YW; Moon HJ
    J Clin Neurol; 2020 Jul; 16(3):408-415. PubMed ID: 32657061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous epileptiform discharges in patients treated with cefepime or meropenem.
    Naeije G; Lorent S; Vincent JL; Legros B
    Arch Neurol; 2011 Oct; 68(10):1303-7. PubMed ID: 21987544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cefepime-induced encephalopathy in patients with renal failure].
    Martín Herrera C; Navarro M
    Nefrologia; 2009; 29(2):181. PubMed ID: 19396333
    [No Abstract]   [Full Text] [Related]  

  • 7. Cefepime-related encephalopathy in peritoneal dialysis patients.
    Lin CJ; Chen SP; Wang SJ; Fuh JL
    J Chin Med Assoc; 2011 Feb; 74(2):87-90. PubMed ID: 21354086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefepime-induced encephalopathy: Neural mass modeling of triphasic wave-like generalized periodic discharges with a high negative component (Tri-HNC).
    Tamune H; Hamamoto Y; Aso N; Yamamoto N
    Psychiatry Clin Neurosci; 2019 Jan; 73(1):34-42. PubMed ID: 30375126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefepime-induced neurotoxicity: a systematic review.
    Payne LE; Gagnon DJ; Riker RR; Seder DB; Glisic EK; Morris JG; Fraser GL
    Crit Care; 2017 Nov; 21(1):276. PubMed ID: 29137682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe but reversible encephalopathy associated with cefepime.
    Jallon P; Fankhauser L; Du Pasquier R; Coeytaux A; Picard F; Hefft S; Assal F
    Neurophysiol Clin; 2000 Dec; 30(6):383-6. PubMed ID: 11191931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefepime-induced encephalopathy in end-stage renal disease patients.
    Nakagawa R; Sato K; Uesaka Y; Mitsuki T; Kondo K; Wake A; Ubara Y; Kanzaki M
    J Neurol Sci; 2017 May; 376():123-128. PubMed ID: 28431597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies.
    Cherif H; Björkholm M; Engervall P; Johansson P; Ljungman P; Hast R; Kalin M
    Scand J Infect Dis; 2004; 36(8):593-600. PubMed ID: 15370671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of Cefepime encephalopathy, being difficult to distinguish from non-convulsive status epilepticus during the treatment of bacterial meningitis].
    Toda Y; Yamazaki M; Ota T; Fujisawa Y; Kimura K
    Rinsho Shinkeigaku; 2016 Oct; 56(10):678-683. PubMed ID: 27680224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefepime neurotoxicity in the intensive care unit: a cause of severe, underappreciated encephalopathy.
    Fugate JE; Kalimullah EA; Hocker SE; Clark SL; Wijdicks EF; Rabinstein AA
    Crit Care; 2013 Nov; 17(6):R264. PubMed ID: 24200036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral manifestations of cefepime toxicity in a dialysis patient.
    Fishbain JT; Monahan TP; Canonico MM
    Neurology; 2000 Dec; 55(11):1756-7. PubMed ID: 11113245
    [No Abstract]   [Full Text] [Related]  

  • 16. Reversible coma secondary to cefepime neurotoxicity.
    Abanades S; Nolla J; Rodríguez-Campello A; Pedro C; Valls A; Farré M
    Ann Pharmacother; 2004 Apr; 38(4):606-8. PubMed ID: 14982986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefepime neurotoxicity: case report, pharmacokinetic considerations, and literature review.
    Lam S; Gomolin IH
    Pharmacotherapy; 2006 Aug; 26(8):1169-74. PubMed ID: 16863493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of bilateral bispectral index (BIS) monitoring in a comatose patient with myoclonic status epilepticus secondary to cefepime.
    Fernández-Torre JL; Hernández-Hernández MA; Rodríguez-Borregán JC; González-Quintanilla V
    Epileptic Disord; 2013 Dec; 15(4):444-50. PubMed ID: 24169368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefepime Induced Encephalopathy in a Non-dialysis Dependent Chronic Kidney Disease Patient: A Case Report.
    Muniandy G; Kamaruzaman L; Jan TH; Mohd R; Neesam MT; Fong Voon K; Pau Kiew B; Mustafar R
    Acta Med Indones; 2023 Jan; 55(1):78-82. PubMed ID: 36999269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonconvulsive status epilepticus due to cefepime in a patient with normal renal function.
    Maganti R; Jolin D; Rishi D; Biswas A
    Epilepsy Behav; 2006 Feb; 8(1):312-4. PubMed ID: 16278098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.